Journal
/
Cancer Research
/
En robust upptäcktsplattform för identifiering av a medlare av melanommetastaser…
JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
En robust upptäcktsplattform för identifiering av nya medlare av melanommetastaser
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/63186-v
•
07:41 min
•
March 8th, 2022
En robust upptäcktsplattform för identifiering av nya medlare av melanommetastaser
March 8th, 2022
•
Arman Alberto Sorin Shadaloey1,2, Alcida Karz1,2, Rana S. Moubarak1,2, Praveen Agrawal1,2, Grace Levinson1,2, Kevin Kleffman1,2, Orlando Aristizabal3,4, Iman Osman2,5, Youssef Z. Wadghiri3,4, Eva Hernando1,2
1Department of Pathology, NYU Grossman School of Medicine, 2Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, 3Department of Radiology, NYU Grossman School of Medicine, 4Preclinical Imaging Core, NYU Grossman School of Medicine, 5Ronald Perelman Department of Dermatology, NYU Grossman School of Medicine
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Denna artikel beskriver ett arbetsflöde av tekniker som används för att testa nya kandidatmedlare av melanommetastaser och deras verkningsmekanismer.